GlaxoSmithKline | GSK - Credores Comerciais

Preço das Ações
1,877.75
Mudança Diária
20.75 1.12%
Mensal
-10.41%
Anual
36.17%
Q2 Previsão
1,868.87




Credores Comerciais Alterar Data
AbbVie USD 3.59B 28.65B 2025-12
Alcon AG USD 926M 31M 2025-12
Almirall EUR 258.05M 58.66M 2025-12
Amgen USD 19.52B 1.37B 2026-03
argenx SE USD 852.2M 369.5M 2025-06
AstraZeneca USD 22.51B 2.78B 2026-03
Bayer EUR 7.08B 700M 2025-12
Biogen USD 358.5M 73.5M 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Eli Lilly USD 5.03B 350M 2026-03
Fresenius EUR 1.08B 65M 2025-09
Fresenius Medical Care EUR 835.55M 109.7M 2025-12
Galapagos EUR 104.65M 4.02M 2025-12
Genmab DKK 6M 2M 2025-09
Gilead Sciences USD 715M 93M 2025-12
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
Glaxosmithkline GBP 20.72B 346.14M 2025-12
GRIFOLS EUR 841M 37.68M 2025-12
Hikma Pharmaceutical USD 715M 104M 2025-12
Lonza CHF 471M 3M 2024-12
Merck EUR 2.11B 182M 2025-12
Merck USD 3.86B 541M 2026-03
Novartis USD 4.32B 134M 2026-03
Novo Nordisk DKK 19.76B 4.15B 2025-12
Orion EUR 150.3M 26.8M 2026-03
Pfizer USD 4.51B 734M 2026-03
Philips EUR 1.93B 214M 2025-12
Recordati EUR 315.05M 15.17M 2025-09
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12
Sanofi EUR 22.71B 219M 2026-03
Smith & Nephew USD 1.19B 73M 2025-12
UCB EUR 4.04B 755M 2025-12